Merck KGaA (MKGAF)
127.60
+1.89
(+1.50%)
USD |
OTCM |
Mar 19, 15:47
Merck EPS Diluted (Quarterly) : 0.854 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MediGene AG | -- |
| InflaRx NV | -0.2115 |
| BioNTech SE | -1.448 |
| Immatics NV | -0.3296 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 377.11M |
| Revenue (Quarterly) | 6.109B |
| Total Expenses (Quarterly) | 5.738B |
| Enterprise Value | 65.57B |
| Gross Profit Margin (Quarterly) | 56.41% |
| Profit Margin (Quarterly) | 6.17% |
| Earnings Yield | 5.30% |
| Operating Earnings Yield | 8.64% |
| Normalized Earnings Yield | 5.772 |